|
| Press Releases |
|
 |
|
| Tuesday, August 30, 2022 |
|
|
宏光半导体公布2022年中期业绩 |
| 宏光半导体有限公司（「宏光半导体」，连同其附属公司统称「集团」；股份代号：6908.HK）欣然宣布其截至2022年6月30日止六个月（「2022年上半年」 或 「期内」）的未经审核之中期业绩。 more info >> |
|
|
宏光半導體公佈2022年中期業績 |
| 宏光半導體有限公司（「宏光半導體」，連同其附屬公司統稱「集團」；股份代號：6908.HK）欣然宣佈其截至2022年6月30日止六個月（「2022年上半年」 或 「期內」）的未經審核之中期業績。 more info >> |
|
|
HG Semiconductor Announces 2022 Interim Results |
| HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group"; stock code: 6908.HK) is pleased to announce its unaudited consolidated results for the six months ended 30 June 2022 (the "first half of 2022" or the "Period"). more info >> |
|
| Monday, August 8, 2022 |
|
|
宏光半导体配售3,000万股新股并宣布协鑫科技创办人朱共山先生认购6,000万股认购股份及6,000万份认股权证 |
| 宏光半导体有限公司（「宏光半导体」，连同其附属公司统称「集团」；股份代号：6908.HK）宣布按配售价每股3.20港元向不少于六名承配人配售3,000万股新股份（「配售股份」）。 more info >> |
|
|
宏光半導體配售3,000萬股新股並宣佈協鑫科技創辦人朱共山先生認購6,000萬股認購股份及6,000萬份認股權證 |
| 宏光半導體有限公司（「宏光半導體」，連同其附屬公司統稱「集團」；股份代號：6908.HK）宣佈按配售價每股3.20港元向不少於六名承配人配售3,000萬股新股份（「配售股份」）。 more info >> |
|
|
HG Semiconductor Places 30 Million New Shares and Announces Subscription of 60 Million Shares and 60 Million Warrants by Founder of GCL Technology Mr. Zhu Gongshan |
| HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group", Stock Code: 6908.HK) has announced placement of 30 million new shares ("Placing Shares") at the placing price of HK$3.20 per share to no less than six placees. more info >> |
|
| Tuesday, June 7, 2022 |
|
|
HG Semiconductor Announced Lock-up Undertakings by Shareholders |
| HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group"; stock code: 6908.HK) is pleased to announce that two of the shareholders of the Group, including major shareholder GSR Capital Special Opportunity Fund L.P. ("GSR Capital") and strategic shareholder Great Ocean Prime Holding Limited ("Great Ocean"), have voluntarily decided not to sell the Group's shares held before May 2024. more info >> |
|
|
宏光半导体公布股东之禁售承诺 |
| 宏光半导体有限公司（「宏光半导体」，连同其附属公司统称「集团」；股份代号：6908.HK）欣然宣布集团之两位股东，包括主要股东GSR Capital Special Opportunity Fund L.P.（「GSR」）以及策略性股东Great Ocean Prime Holding Limited（「Great Ocean」），自愿决定于2024年5月前将不会出售所持集团的股份。 more info >> |
|
|
宏光半導體公佈股東之禁售承諾 |
| 宏光半導體有限公司（「宏光半導體」，連同其附屬公司統稱「集團」；股份代號：6908.HK）欣然宣佈集團之兩位股東，包括主要股東GSR Capital Special Opportunity Fund L.P.（「GSR」）以及策略性股東Great Ocean Prime Holding Limited（「Great Ocean」），自願決定於2024年5月前將不會出售所持集團的股份。 more info >> |
|
| Thursday, June 2, 2022 |
|
|
HG Semiconductor Enters into Cooperation Framework Agreement with China Titans Energy |
| HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group"; stock code: 6908.HK) is pleased to announce that the Group entered into a cooperation framework agreement ("Cooperation Framework Agreement") with China Titans Energy Technology Group Co., Limited ("China Titans Energy"; Stock Code: 2188.HK) on 31 May 2022, to commence three-year strategic cooperation. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation
Mar 14, 2026 05:00 HKT/SGT
|
|
|
General MRO Aerospace 取得中國民航局認證，拓展全球維修能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace 获得中国民航局认证，拓展全球维护能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities
Mar 13, 2026 22:20 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00: JST
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT/SGT
|
|
|
CITIC Resources Deepens Dual-Engine Strategy of 'Investment + Trading', Continues to Promote High-Quality Development
Mar 13, 2026 21:01 HKT/SGT
|
|
|
中信資源深化「投資+貿易」雙輪戰略 持續驅動高質量發展 推進「上游資產布局、貿易業務拓展、生產運營提質」
Mar 13, 2026 20:53 HKT/SGT
|
|
|
中信资源深化「投资+贸易」双轮战略 持续驱动高质量发展 推进「上游资产布局、贸易业务拓展、生产运营提质」
Mar 13, 2026 20:40 HKT/SGT
|
|
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT/SGT
|
|
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 18:00: JST
|
|
|
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating "Online x Offline" O2O Community Finance Strategy
Mar 13, 2026 17:34 HKT/SGT
|
|
|
盈立證券一年拓展12個服務網點 全力深化「線上x線下」O2O社區金融佈局
Mar 13, 2026 17:21 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
